Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions

Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients

(2017) M.-S. Hong et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

“Genetic regulation of Mycobacterium tuberculosis in a lipid-rich environment”

(2017) Diana A. Aguilar-Ayala et al.   INFECTION GENETICS AND EVOLUTION

Antibiotic tolerance facilitates the evolution of resistance

(2017) Irit Levin-Reisman et al.   SCIENCE

Cholesterol plays a larger role during Mycobacterium tuberculosis in vitro dormancy and reactivation than previously suspected

(2017) Maria D. Soto-Ramirez et al.   TUBERCULOSIS

Mycobacterial Dormancy Systems and Host Responses in Tuberculosis

(2017) Vidyullatha Peddireddy et al.   Frontiers in Immunology

Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing

(2017) Selvi C. Ersoy et al.   EBioMedicine

New Evidence for the Complexity of the Population Structure ofMycobacterium tuberculosisIncreases the Diagnostic and Biologic Challenges

(2016) Véronique Dartois et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria

(2016) Isha Soni et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB

(2016) David A. Barr et al.   TUBERCULOSIS

Activity of Drugs Against DormantMycobacterium tuberculosis

(2014) G. Piccaro et al.   JOURNAL OF CHEMOTHERAPY

Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis

(2013) Matthew W. Carroll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dormancy Is Not Necessary or Sufficient for Bacterial Persistence

(2013) Mehmet A. Orman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of Drug Combinations against Mycobacterium tuberculosis Grown in Aerobic and Hypoxic Acidic Conditions

(2013) Giovanni Piccaro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Metabolic Control of Persister Formation in Escherichia coli

(2013) Stephanie M. Amato et al.   MOLECULAR CELL

Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study

(2013) Josephine M Bryant et al.   Lancet Respiratory Medicine

Heterogeneous bacterial persisters and engineering approaches to eliminate them

(2011) Kyle R Allison et al.   CURRENT OPINION IN MICROBIOLOGY

Activity of Drug Combinations against Dormant Mycobacterium tuberculosis

(2010) P. Filippini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY